06.20.11
Citicoline may help improve sustained attention by enhancing the brain’s capacity to focus on a single task, according to new research presented recently by members of the University of Utah Brain Institute at the New Clinical Drug Evaluation Unit (NCDEU) annual meeting.
Sixty healthy women ages 40-60 participated in this double-blind, placebo-controlled three-arm study. After an initial performance test to measure attentional function, they were divided into three groups of 20 and began supplementation with either 250 mg or 500 mg of citicoline (the researchers used Cognizin citicoline from Kyowa Hakko) or placebo. Results after supplementation showed that individuals receiving either the low or high dose of citicoline produced fewer errors during performance testing. Findings suggest citicoline supplementation, at 250 mg, provided improved attention when required, due to the inhibition of incorrect responses. For further information: www.cognizin.com
Sixty healthy women ages 40-60 participated in this double-blind, placebo-controlled three-arm study. After an initial performance test to measure attentional function, they were divided into three groups of 20 and began supplementation with either 250 mg or 500 mg of citicoline (the researchers used Cognizin citicoline from Kyowa Hakko) or placebo. Results after supplementation showed that individuals receiving either the low or high dose of citicoline produced fewer errors during performance testing. Findings suggest citicoline supplementation, at 250 mg, provided improved attention when required, due to the inhibition of incorrect responses. For further information: www.cognizin.com